HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A new micronized formulation of 2-methoxyestradiol-bis-sulfamate (STX140) is therapeutically potent against breast cancer.

AbstractUNLABELLED:
There is a continued need for orally bioavailable anticancer compounds that exhibit good efficacy against breast cancer. STX140, a derivative of 2-methoxyestradiol (2-MeOE2), has been shown to have excellent oral bioavailability and significantly reduces tumor growth. A new micronized formulation of STX140 has now been developed and its pharmacokinetics (PK) in rats and effect on MDA-MB-231 breast cancer growth in nude mice was investigated.
MATERIALS AND METHODS:
For the PK studies, female Wistar rats were treated orally with STX140 in two separate vehicles (10% tetrahydrofuran (THF) in propylene glycol (PG) or 0.5% methyl cellulose (MC) in saline) and plasma samples taken for high performance liquid chromatography analysis over 48 h. For the tumor efficacy studies, female nude mice were inoculated with MDA-MB-231 breast cancer cells and then treated orally with a range of doses of STX140.
RESULTS:
The PK studies demonstrated that the THF/PG vehicle resulted in a greater oral bioavailability of STX140 compared to the 0.5% MC vehicle. However, this was not translated to the tumor efficacy studies where STX140 at 20 mg/kg in either vehicle caused a significant reduction in tumor volume.
CONCLUSION:
The new micronized formulation of STX140 is orally bioavailable and efficacious at inhibiting MDA-MB-231 breast tumor growth.
AuthorsPaul A Foster, Simon P Newman, Mathew P Leese, Sonia Bernetiere, Christian Diolez, Jose Camara, Beatrice Hacher, Marie-Madeleine Baronnet, Tauhid Ali, Barry V L Potter, Michael J Reed, Atul Purohit
JournalAnticancer research (Anticancer Res) 2008 Mar-Apr Vol. 28 Issue 2A Pg. 577-81 ISSN: 0250-7005 [Print] Greece
PMID18506995 (Publication Type: Comparative Study, Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 2-methoxyestradiol-3,17-O,O-bis(sulfamate)
  • Dosage Forms
  • Estrenes
Topics
  • Administration, Oral
  • Animals
  • Cell Line, Tumor
  • Dosage Forms
  • Estrenes (administration & dosage, pharmacokinetics, therapeutic use)
  • Female
  • Male
  • Mammary Neoplasms, Experimental (drug therapy, metabolism)
  • Mice
  • Mice, Nude
  • Rats
  • Rats, Sprague-Dawley
  • Viscosity
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: